These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 15265562)
21. Pharmacokinetics of Orally Administered Poly(Ethylene Oxide)-block-Poly(ε-Caprolactone) Micelles of Cyclosporine A in Rats: Comparison with Neoral®. Binkhathlan Z; Ali R; Qamar W; Lavasanifar A J Pharm Pharm Sci; 2018; 21(1s):192s-199s. PubMed ID: 30139426 [TBL] [Abstract][Full Text] [Related]
22. [Study on preparation conditions for polylactide nanoparticles loaded cyclosporine A and its oral bioavailability in rats]. Wang XQ; Zhang T; He Y; Zhang L; Zhang Q Yao Xue Xue Bao; 2004 Jan; 39(1):68-71. PubMed ID: 15127586 [TBL] [Abstract][Full Text] [Related]
23. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. Mittal G; Sahana DK; Bhardwaj V; Ravi Kumar MN J Control Release; 2007 May; 119(1):77-85. PubMed ID: 17349712 [TBL] [Abstract][Full Text] [Related]
24. Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt. Guan P; Lu Y; Qi J; Niu M; Lian R; Hu F; Wu W Int J Nanomedicine; 2011; 6():965-74. PubMed ID: 21720508 [TBL] [Abstract][Full Text] [Related]
25. Ophthalmic delivery of Cyclosporine A from Brij-97 microemulsion and surfactant-laden p-HEMA hydrogels. Kapoor Y; Chauhan A Int J Pharm; 2008 Sep; 361(1-2):222-9. PubMed ID: 18577433 [TBL] [Abstract][Full Text] [Related]
26. Pulmonary delivery of intratracheally instilled and aerosolized cyclosporine A to young and adult rats. Taljanski W; Pierzynowski SG; Lundin PD; Westrom BR; Eirefelt S; Podlesny J; Dahlback M; Siwinska-Golebiowska H; Karlsson BW Drug Metab Dispos; 1997 Aug; 25(8):917-20. PubMed ID: 9280398 [TBL] [Abstract][Full Text] [Related]
27. [Influence of suspending agents on relative bioavailability of cyclosporine A-loaded HPMCP nanoparticles for oral administration to rats]. Wang XQ; Chen Z; Dai JD; Zhang T; Xia GM; Zhang Q Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 36(3):305-8. PubMed ID: 15205706 [TBL] [Abstract][Full Text] [Related]
28. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs. Hu L; Tang X; Cui F J Pharm Pharmacol; 2004 Dec; 56(12):1527-35. PubMed ID: 15563759 [TBL] [Abstract][Full Text] [Related]
29. Mechanisms of phospholipid complex loaded nanoparticles enhancing the oral bioavailability. Peng Q; Zhang ZR; Sun X; Zuo J; Zhao D; Gong T Mol Pharm; 2010 Apr; 7(2):565-75. PubMed ID: 20166756 [TBL] [Abstract][Full Text] [Related]
30. Oral insulin delivery using nanoparticles based on microemulsions with different structure-types: optimisation and in vivo evaluation. Graf A; Rades T; Hook SM Eur J Pharm Sci; 2009 Apr; 37(1):53-61. PubMed ID: 19167488 [TBL] [Abstract][Full Text] [Related]
31. Improved bioavailability of orally administered mifepristone from PLGA nanoparticles. He W; Horn SW; Hussain MD Int J Pharm; 2007 Apr; 334(1-2):173-8. PubMed ID: 17101249 [TBL] [Abstract][Full Text] [Related]
32. Biodegradable in situ gelling system for subcutaneous administration of ellagic acid and ellagic acid loaded nanoparticles: evaluation of their antioxidant potential against cyclosporine induced nephrotoxicity in rats. Sharma G; Italia JL; Sonaje K; Tikoo K; Ravi Kumar MN J Control Release; 2007 Mar; 118(1):27-37. PubMed ID: 17258836 [TBL] [Abstract][Full Text] [Related]
33. Improvement of cyclosporine A bioavailability by incorporating ethyl docosahexaenoate in the microemulsion as an oil excipient. Hirunpanich V; Sato H Eur J Pharm Biopharm; 2009 Oct; 73(2):247-52. PubMed ID: 19560537 [TBL] [Abstract][Full Text] [Related]
34. Cicloral versus neoral: a bioequivalence study in healthy volunteers on the influence of a fat-rich meal on the bioavailability of cicloral. Kees F; Mair G; Dittmar M; Bucher M Transplant Proc; 2004 Dec; 36(10):3234-8. PubMed ID: 15686736 [TBL] [Abstract][Full Text] [Related]
35. Bioavailability and pharmacokinetics of sorafenib suspension, nanoparticles and nanomatrix for oral administration to rat. Wang XQ; Fan JM; Liu YO; Zhao B; Jia ZR; Zhang Q Int J Pharm; 2011 Oct; 419(1-2):339-46. PubMed ID: 21843612 [TBL] [Abstract][Full Text] [Related]
36. Preparation of biodegradable cyclosporine nanoparticles by high-pressure emulsification-solvent evaporation process. Jaiswal J; Gupta SK; Kreuter J J Control Release; 2004 Apr; 96(1):169-78. PubMed ID: 15063039 [TBL] [Abstract][Full Text] [Related]
37. Mechanism of decrease of oral bioavailability of cyclosporin A during immunotherapy upon coadministration of amphotericin B. Ishizaki J; Ito S; Jin M; Shimada T; Ishigaki T; Harasawa Y; Yokogawa K; Takami A; Nakao S; Miyamoto K Biopharm Drug Dispos; 2008 May; 29(4):195-203. PubMed ID: 18240156 [TBL] [Abstract][Full Text] [Related]
38. Ethyl docosahexaenoate decreased Neoral absorption due to particle size enlargement. Hirunpanich V; Sugiyama E; Sato H Int J Pharm; 2008 Sep; 361(1-2):251-2. PubMed ID: 18577438 [TBL] [Abstract][Full Text] [Related]
39. [Effect of particle size on oral absorption of silymarin-loaded solid lipid nanoparticles]. He J; Hou SX; Feng JF; Cai BQ Zhongguo Zhong Yao Za Zhi; 2005 Nov; 30(21):1651-3. PubMed ID: 16400939 [TBL] [Abstract][Full Text] [Related]
40. Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy. Mukherjee S; Ray S; Thakur RS Pak J Pharm Sci; 2009 Apr; 22(2):131-8. PubMed ID: 19339221 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]